Abstract: The present invention relates to novel Mannose-binding lectin (MBL)-associated serine protease (MASP) inhibitory bicyclic compounds, as well as to processes for the preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of renal and cardiovascular disorders and of ischemia reperfusion injuries.

Abstract: The present invention provides a multifunctional aromatherapy machine, including a water tank and a pedestal, wherein an aluminum ring is arranged between the water tank and the pedestal, and a circuit board, an atomizing sheet and an atomizing sheet pressing plate are arranged on the pedestal; the circuit board includes a control circuit, a power interface, a timing indicator lamp and a foglight knob are arranged on an outer side wall of the pedestal respectively, and a chassis induces the power interface. The multifunctional aromatherapy machine provided by the present invention has the characteristics of diversified functions, capability of controlling a plurality of functions with one key, convenience in use, low cost, convenience in maintenance and the like.

Abstract: The present disclosure provides a humidifier, which includes a body, a switch controlling the humidifier to turn on or off is set on the body. A connecting line and a connecting plug that can connect to a electric source are also set on the body, and the connecting switch controlling the connection to the electric source is located on the connecting line or the connecting plug. Due to the connecting switch, combining with an original on-off switch on the humidifier body, the humidifier can be controlled by double switches, thereby improving of the convenience of the use of the humidifier.

Abstract: The present application discloses a clothes tag, relating to the field of a tag. The clothes tag includes a casing provided with an anti-theft clasp and a screen inserted on one side thereof for showing the information of clothes. Regarding the problem of losing its shape present in clothes for having too many accessories hanged thereon in the prior art, the tag according to the present application is provided with the anti-theft clasp and the screen, so to reduce the accessories to be handed on clothes and improve the trying-on experience of a client. In addition, the information shown on the screen can be changed as needed, achieving repeated use of the tag according to the present application.

Abstract: The present application discloses a clothes tag, relating to the field of a tag. The clothes tag includes a casing provided with an anti-theft clasp and a screen inserted on one side thereof for showing the information of clothes. Regarding the problem of losing its shape present in clothes for having too many accessories hanged thereon in the prior art, the tag according to the present application is provided with the anti-theft clasp and the screen, so to reduce the accessories to be handed on clothes and improve the trying-on experience of a client. In addition, the information shown on the screen can be changed as needed, achieving repeated use of the tag according to the present application.

Abstract: A method for indicating and alarming about wet level of a diaper involves using a humidity sensor to perform relative humidity detection on the diaper, when the detected relative humidity is below 50% rh˜60% rh, showing the diaper's wet level as 0% rh, and when the detected relative humidity is 85% rh˜95% rh or more, showing the diaper's wet level as 100% rh, wherein functional conversion is performed to convert the relative humidity ranging between 60% rh and 85% rh˜95% rh proportionally into the diaper's wet level between 0% rh and 100% rh.

Abstract: A method for indicating and alarming about wet level of a diaper involves using a humidity sensor to perform relative humidity detection on the diaper, when the detected relative humidity is below 50% rh˜60% rh, showing the diaper's wet level as 0% rh, and when the detected relative humidity is 85% rh˜95% rh or more, showing the diaper's wet level as 100% rh, wherein functional conversion is performed to convert the relative humidity ranging between 60% rh and 85% rh˜95% rh proportionally into the diaper's wet level between 0% rh and 100% rh.

Abstract: A method for detecting an infant's urination includes: determining that Condition 1 is satisfied if a relative humidity value collected lastly is greater than humidity values of previous N times and is 1% rh˜3% rh greater than a minimum of the previous N times; determining that Condition 2 is satisfied and the first urination has happened if humidity values collected in continuous M times satisfy Condition 1, and the humidity value collected in the Mth time is 3% rh˜6% rh greater than a minimum of the previous N+M times; starting to detect a second urination when humidity variation becomes steady; and determining that the second urination has happened if a time for humidity to increase 0.1% rh is less than a half of a previous time for humidity to increase 0.1% rh, and a next time for humidity to increase 0.1% rh is also less than a half of the previous time.

Abstract: The present invention provides for the identification, isolation and uses of mammalian Monoamine Oxidase C (MAO-C), also known as renalase.

Abstract: The present invention provides for the identification, isolation and uses of mammalian Monoamine Oxidase C (MAO-C), also known as renalase.

Abstract: The present invention provides methods of using Monoamine Oxidase C (MAO-C), also known as renalase, as a therapeutic protein in its active and inactive forms. Administering inactive renalase protein to individuals with lower renalase levels can be used to provide them with an adequate pool of the protein that can be activated by the body as needed. Active renalase protein can be administered to individuals needing an immediate reduction of catecholamine levels. An inhibitor of renalase may be used to enhance adrenergic action.

Abstract: The present invention provides methods of using Monoamine Oxidase C (MAO-C), also known as renalase, as a therapeutic protein in its active and inactive forms. Administering inactive renalase protein to individuals with lower renalase levels can be used to provide them with an adequate pool of the protein that can be activated by the body as needed. Active renalase protein can be administered to individuals needing an immediate reduction of catecholamine levels. An inhibitor of renalase may be used to enhance adrenergic action.

Abstract: The present invention provides for the identification, isolation and uses of mammalian Monoamine Oxidase C (MAO-C), also known as renalase.

Abstract: The present invention provides for the identification, isolation and uses of mammalian Monoamine Oxidase C (MAO-C), also known as renalase.

Abstract: The present invention provides for the identification, isolation and uses of mammalian Monoamine Oxidase C (MAO-C), also known as renalase.

Abstract: The present invention provides methods of using Monoamine Oxidase C (MAO-C), also known as renalase, as a therapeutic protein in its active and inactive forms. Administering inactive renalase protein to individuals with lower renalase levels can be used to provide them with an adequate pool of the protein that can be activated by the body as needed. Active renalase protein can be administered to individuals needing an immediate reduction of catecholamine levels. An inhibitor of renalase may be used to enhance adrenergic action.

Abstract: The present invention relates to weight control, control of body fat and food intake, and provides useful methods for treating, inter alia, obesity, diabetes and insulin insensitivity, and conditions, diseases, and disorders relating thereto. The invention also relates to methods of identifying useful compounds relating to weight loss, food intake, diabetes, and obesity, among other things, based on the discovery that inhibiting Kv1.3 activity mediates decreased food intake, weight loss, decreased body fat, increase glucose uptake, and increased insulin sensitivity, among other things.

Abstract: The present invention relates to weight control, control of body fat and food intake, and provides useful methods for treating, inter alia, obesity, diabetes and insulin insensitivity, and conditions, diseases, and disorders relating thereto. The invention also relates to methods of identifying useful compounds relating to weight loss, food intake, diabetes, and obesity, among other things, based on the discovery that inhibiting Kv1.3 activity mediates decreased food intake, weight loss, decreased body fat, increase glucose uptake, and increased insulin sensitivity, among other things.